Compounds > staurosporine
Page last updated: 2024-08-23

staurosporine and cholest-5-ene-3,4-diol

staurosporine has been researched along with cholest-5-ene-3,4-diol in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dutreix, C; Lorenzo, S; Wang, Y1
Chun, DY; Dutreix, C; Einolf, HJ; Gu, H; He, H; Ouatas, T; Rebello, S; Wang, L1

Trials

1 trial(s) available for staurosporine and cholest-5-ene-3,4-diol

ArticleYear
Comparison of two endogenous biomarkers of CYP3A4 activity in a drug-drug interaction study between midostaurin and rifampicin.
    European journal of clinical pharmacology, 2014, Volume: 70, Issue:8

    Topics: Adult; Biomarkers; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inducers; Drug Interactions; Female; Humans; Hydrocortisone; Hydroxycholesterols; Male; Middle Aged; Protein Kinase Inhibitors; Rifampin; Staurosporine; Young Adult

2014

Other Studies

1 other study(ies) available for staurosporine and cholest-5-ene-3,4-diol

ArticleYear
Simultaneous Physiologically Based Pharmacokinetic (PBPK) Modeling of Parent and Active Metabolites to Investigate Complex CYP3A4 Drug-Drug Interaction Potential: A Case Example of Midostaurin.
    Drug metabolism and disposition: the biological fate of chemicals, 2018, Volume: 46, Issue:2

    Topics: Adult; Biomarkers; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inducers; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Female; Humans; Hydroxycholesterols; Ketoconazole; Male; Midazolam; Middle Aged; Models, Biological; Rifampin; Staurosporine; Young Adult

2018